Wang XY, Zhang YB, Mu RX, Cui LB, Wang HN. Repetitive transcranial magnetic stimulation enhanced by neuronavigation in the treatment of depressive disorder and schizophrenia. World J Psychiatry 2024; 14(11): 1618-1622 [PMID: 39564180 DOI: 10.5498/wjp.v14.i11.1618]
Corresponding Author of This Article
Hua-Ning Wang, MD, PhD, Associate Chief Physician, Associate Professor, Director, Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, No. 127 Changle West Road, Xincheng District, Xi’an 710032, Shaanxi Province, China. xskzhu@fmmu.edu.cn
Research Domain of This Article
Psychiatry
Article-Type of This Article
Editorial
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
World J Psychiatry. Nov 19, 2024; 14(11): 1618-1622 Published online Nov 19, 2024. doi: 10.5498/wjp.v14.i11.1618
Repetitive transcranial magnetic stimulation enhanced by neuronavigation in the treatment of depressive disorder and schizophrenia
Xian-Yang Wang, Yuan-Bei Zhang, Rong-Xue Mu, Long-Biao Cui, Hua-Ning Wang
Xian-Yang Wang, Yuan-Bei Zhang, Long-Biao Cui, Schizophrenia Imaging Laboratory, Xijing 986 Hospital, Fourth Military Medical University, Xi’an 710054, Shaanxi Province, China
Rong-Xue Mu, Simon Fraser University, Vancouver V5A1S6, British Columbia, Canada
Long-Biao Cui, Shaanxi Provincial Key Laboratory of Clinic Genetics, Fourth Military Medical University, Xi’an 710032, Shaanxi Province, China
Long-Biao Cui, Department of Radiology, The First Affiliated Hospital of Xi’an Jiaotong University, Xi’an 710061, Shaanxi Province, China
Hua-Ning Wang, Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, Xi’an 710032, Shaanxi Province, China
Co-first authors: Xian-Yang Wang and Yuan-Bei Zhang.
Author contributions: Wang XY and Zhang YB contributed to the writing, and editing the manuscript, illustrations, and review of literature; Cui LB and Wang XY contributed to the discussion and design of the manuscript; Cui LB and Wang HN designed the overall concept and outline of the manuscript; all of the authors read and approved the final version of the manuscript to be published.
Supported by The National Natural Science Foundation of China, No. 82271949; The Youth Project of General Items for Shaanxi Natural Science Foundation, No. 2022JQ-908; and The Key Research and Development Program of Shaanxi Province, No. 2023-YBSF-444.
Conflict-of-interest statement: All authors declare no conflict of interest in publishing the manuscript.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Hua-Ning Wang, MD, PhD, Associate Chief Physician, Associate Professor, Director, Department of Psychiatry, Xijing Hospital, Fourth Military Medical University, No. 127 Changle West Road, Xincheng District, Xi’an 710032, Shaanxi Province, China. xskzhu@fmmu.edu.cn
Received: May 13, 2024 Revised: September 23, 2024 Accepted: October 18, 2024 Published online: November 19, 2024 Processing time: 178 Days and 16.8 Hours
Abstract
This editorial assesses the advancements in neuronavigation enhanced repetitive transcranial magnetic stimulation for depressive disorder and schizophrenia treatment. Conventional repetitive transcranial magnetic stimulation faces challenges due to the intricacies of brain anatomy and patient variability. Neuronavigation offers innovative solutions by integrating neuroimaging with three-dimensional localization to pinpoint brain regions and refine therapeutic targeting. This systematic review of recent literature underscores the enhanced efficacy of neuronavigation in improving treatment outcomes for these disorders. This editorial highlights the pivotal role of neuronavigation in advancing psychiatric care.
Core Tip: Neuronavigation enhanced repetitive transcranial magnetic stimulation offers a promising avenue for treating depressive disorder and schizophrenia by addressing anatomical complexities and individual variabilities. By integrating neuroimaging data and three-dimensional positioning, neuronavigation enables precise localization of brain structures, optimizing therapeutic target selection. This article highlights its efficacy in clinical cases, indicating diverse target selection based on structural or functional alterations among patients. This innovative approach heralds a crucial advancement in mental health treatment, underscoring the importance of integrating neuronavigation technology to enhance therapeutic outcomes.
